📢 Important update on FDA mandate for CAR-T therapies The FDA recently required the manufacturers of six licensed CAR-T cancer treatments to add boxed warnings to their product labels. The requirement has implications for sponsors with approved therapies and those in development. In this edition, Parexel's Mwango Kashoki MD MPH, former Associate Director for Safety in FDA’s Office of New Drugs, shares insights and guidance to navigate this. Like and subscribe for more #NovelInsights! #FDA #oncology
I'm curious
Results-driven R&D Project/Product Manager 💊🧬 | Expert in Organic Formulation | Holds a Master's degree in Biotechnology Engineering
6moThank you for